Papers In Press, published online ahead of print October 6, 2006
J. Biol. Chem, 10.1074/jbc.M602119200
Submitted on March 6, 2006
Revised on October 6, 2006
Accepted on October 6, 2006
Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases
Lincoln D. Nadauld, Reid Phelps, Brent C. Moore, Annie Eisinger, Imelda T. Sandoval, Stephanie Chidester, Peter W. Peterson, Elizabeth J. Manos, Bradford Sklow, Randall W. Burt, and David A. Jones
Huntsman Cancer Institute, Salt Lake City, UT 84112
Corresponding Author: david.jones{at}hci.utah.edu
Mutations in the human adenomatous polyposis coli (APC) gene are thought to initiate colorectal tumorigenesis. The tumor suppressor function of APC is attributed primarily to its ability to regulate the WNT pathway by targeting the destruction of ß-catenin. We report here a novel role for APC in regulating degradation of the transcriptional co-repressor c-terminal binding protein-1 (CtBP1) through a proteasome-dependent process. Further, CtBP1 suppresses the expression of intestinal retinol dehydrogenases, which are required for retinoic acid production and intestinal differentiation. In support of a role for CtBP1 in initiation of colorectal cancer, adenomas taken from individuals with familial adenomatous polyposis contain high levels of CtBP1 protein in comparison to matched, uninvolved tissue. The relationship between APC and CtBP1 is conserved between humans and zebrafish and provides a mechanistic model explaining APC control of intestinal retinoic acid biosynthesis.